MAMMALS ARE BORN WITH A SYSTEMIC and mucosal adaptive immune system that is immature and incapable of providing sufficient protection against the wide assortment of antigens and bacteria that are encountered after birth (34) . Many mammals, including humans, acquire passive immunity by transplacental flow of maternal IgG and through breast milk, which is a rich source of both IgG and secretory IgA. In those species that obtain IgG in utero, the most abundant immunoglobulin in breast milk is secretory IgA, which is unabsorbed and represents the main component of the humoral mucosal immune system during the suckling period of development. The in utero transfer of IgG is absent in other species including rodents, cattle, pigs, sheep, and horses, whereas as neonates, serum levels of IgG in these species are entirely dependent on passive transfer from breast milk (7) .
The receptor that transfers maternally derived IgG to the systemic circulation of suckling animal is the Fc receptor of the neonate (FcRn) (28) . FcRn is expressed by syncytiotrophoblast of the placenta, where it mediates the transplacental transfer of IgG (14) . In the small intestine of suckling mammals, FcRn is expressed by enterocytes located along the entire length of the crypt-to-villus axis and is responsible for the uptake of luminal IgG across the epithelial layer (1) . In rodents, FcRn mRNA levels are most abundant in the duodenum, and steadily decline along the horizontal axis of the small bowel (10, 18) . In humans, FcRn has been detected in intestinal epithelial cells, where it may play a role in sampling luminal antigens and possibly mediate the transfer of IgG during breast feeding (27) .
FcRn is a heterodimer that is noncovalently bound to ␤ 2 -microglobulin and is related to the family of nonclassic major histocompatibility complex (MHC) class Ib proteins (23) . FcRn transports IgG, in a process termed transcytosis, from apical (intestinal lumen) to basolateral membranes (systemic circulation) (2) . At the apical membrane, IgG-FcRn complexes form at an acidic pH and are endocytosed in clathrin-coated vesicles, which subsequently sort to intermediate compartments before trafficking to the basolateral membrane. At the basolateral membrane, the complex dissociates at the neutral pH, and IgG is released into the systemic circulation (25) . Overall, FcRn serves an essential role in controlling the transfer of IgG from the maternal to the fetal/newborn circulation of all mammals.
In rodents and other mammals, the systemic humoral IgG immune system matures shortly after the cessation of breast feeding, and steady-state FcRn mRNA levels in the small bowel decline dramatically in weaned animals to nearly undetectable levels (10, 17, 18) . The FcRn mRNA transcript has also been detected at much lower quantities in liver and vascular endothelial cells compared with levels seen in the small bowel of suckling animals (2) . In vascular endothelial cells, FcRn has been shown to represent the "Brambell receptor" and control the extremely low rate of IgG catabolism (3, 11) . Interestingly, hypogammaglobulinemia attributable to rapid IgG catabolism has been described in myotonic dystrophy and in a rare autosomal recessive disorder (OMIM 241600) (31, 32) . Therefore, in humans, the FcRn protein controls serum IgG levels and may sample luminal antigens for presentation to the mucosal adaptive immune system. Insufficient information is currently available regarding the regulation of the FcRn expression. Corticosteroids, thyroxine, EGF, and insulin have all been shown to decrease IgG transfer via the intestinal enterocyte of suckling animals (30) . We have reported that the administration of either corticosteroids or thyroxine to suckling pups abolishes both IgG absorption and FcRn mRNA expression in a dose-and time-dependent manner (16) . The reduction of FcRn expression in endothelial cells may explain the benefit of steroids and intravenous immunoglobulins in the management of various autoimmune disorders (16, 33) .
Whereas the sequences of the human and murine FcRn genes have been reported, the elements that are critical in directing FcRn promoter activity have not been identified (12, 22) . In a recent analysis of the human promoter, several elements were identified that form complexes with nuclear extracts; however, the study failed to adequately define the important elements that drive FcRn gene expression (22) . To further characterize the mechanism of how the FcRn gene is regulated, we cloned the upstream region of the rat gene and identified the cis-acting elements that control its basal expression.
MATERIALS AND METHODS

Isolation and Characterization of Rat Genomic Clones
Approximately 10
6 recombinant phage clones from a rat (Sprague Dawley) genomic library (Stratagene) were plated and blotted in duplicate on nitrocellulose filters. The filters were screened with a PCR-derived cDNA corresponding to nucleotides 500 to 1000 by standard methods (19, 28) . Liquid phage stocks were produced of the phage clones that remained positive after tertiary screening, and we performed genomic mapping by digesting DNA with partial or double restriction enzymes that included BamHI, EcoRI, HindIII, and SmaI (New England Biolaboratories). DNA was fractionated on a 0.4% agarose gel, transferred to nitrocellulose filters, and hybridized to [␥-P 32 ]dATP (New England Nuclear Research Products) end-labeled oligonucleotides including T3, T7, and regions internal to the FcRn cDNA.
Intron/Exon Mapping and DNA Sequence Analysis
Genomic DNA containing each of the exons was digested, subcloned into Bluescript SKI (Ϫ), and purified by the standard Qiagen method. Each exon, the intron/exon boundary and 2.9 Kb of the 5Ј upstream region, was sequenced by the dideoxy method with [␣-
35 S]dATP (New England Nuclear Research Products) and Sequenase 2 (United States Biochemical).
RNase Protection and Northern Blot Analysis
RNase protection assay was performed according to previously described methods (10) . Specifically, total RNA was isolated by standard guanidine-phenol extraction methods and hybridized to radiolabeled ␣-sense riboprobe. After overnight incubation in a specific buffer, the mixture will be digested with RNaseA/T1 mixture for 30 min and electrophoresed on a polyacrylamide gel. Northern blot analysis was performed with 20 g of total RNA isolated as previously described from Caco-2, HT-29, IEC-6, and endothelial SV40 cells (29) . The human (Caco-2 and HT-29) and rodent (IEC-6, endothelial SV40) RNA samples were hybridized to the human or rat cDNA probe, respectively.
DNA Cloning and Substitution Mutagenesis
The FcRn #1 phage clone was digested with EcoRI, and the 3.3-Kb fragment was subcloned into a similarly digested pBluescript vector. The vector was then digested with BamHI, and a 2.9-Kb fragment was subcloned into the BglII site of the reporter clone pGL3-basic (Promega). The orientation was confirmed by sequencing, and the pGL3-basic 2.9-Kb FcRn clone was used to generate nested deletion clones whose size was confirmed by sequencing. Six sense, Ϫ450/Ϫ430 (5Ј-gca gat ctT CCT GAC AAG ATC TTG GGT TG), Ϫ300/Ϫ283 (5Ј-gca gat ctG AGA GTG GGC TGC AGC AGG), Ϫ216/Ϫ198 (5Ј-gca gat ctT GCT CAG AAT GAG TAA ACA C), Ϫ157/Ϫ139 (5Ј-gca gat ctT GCT CAG AAT GAG TAA ACA C), Ϫ101/Ϫ95 (5Ј-gca gat ctC CCC AGG AGG CTT CCA GA), and Ϫ58/Ϫ40 (5Ј-gca gat ctT GCT TAA GAG CTC GTG GGG T) and an antisense ϩ113/ϩ80 (5Ј-ata agc ttC CCT CTT CCT CAC AGA AGC C) oligonucleotides were developed to amplify various shorter-length products from rat genomic DNA. The fragments were digested with HindIII/BglII (restriction site indicated in lowercase lettering) and subcloned into the pGL 3-enhancer luciferase reporter vector (Promega). Clones rFcRn
/E-Luc, and rFcRn Ϫ58/ϩ135 /E-Luc were sequenced to define their size and authenticity.
To define the nucleotides within the core promoter that were critical to maintain the gene's basal level of expression, 20 clones containing 10-bp mutations were produced by standard scanning mutagenesis. The location of each mutation is shown in Fig. 1 . Mutagenizing oligonucleotides that contain 10-bp central transversion mutations (A-C, G-T) were designed and used to perform PCR with the antisense (ϩ113/ϩ80) oligonucleotide ( Table 1 ). The PCR products were gel purified and with the addition of a sense (Ϫ157/Ϫ139) oligonucleotide, a second PCR reaction was performed to generate clones with 10-bp mutations. The full-length fragments were cut with BglII/HindIII, gel purified, and subcloned into the pGL3-E vector. All clones were sequenced to verify the presence of only the desired mutation.
Drosophila SL2 cells were used to assess the role of the Sp family of transcription factors in controlling promoter activity. Because Sp1 alters the promoter activity of promoterless pGL3-basic, the wild-type FcRn's minimal promoter (Ϫ157/ϩ135) was subcloned into p␤-Galactosidase (␤-Gal)-basic (Clontech) (13) .
Cell Transfection Procedure
Caco-2, 3T3, Chinese hamster ovary (CHO), HeLa, and m-IC cl2 (kindly provided by Alain Vandewalle) cells were transfected with a calcium phosphate reagents as previously described (21) . IEC-6 cells were electroporated with a BioRad RF module. Each pulse had 10 g of luciferase construct and 1 g of renilla vector for 4 ϫ 10 6 cells. This mixture was then pulsed at 0% modulation, 0.2 kV, 50 Hz, for 2 ms, with 1-s intervals for five bursts. Cells were incubated for 48 h, rinsed with PBS, and lysed in SDS containing buffer (Analytical Luminescence Laboratory), and extracts were stored at Ϫ80°C. Both luciferase and renilla were measured as previously described (29) .
Drosophila SL2 cells were maintained in Schneider's insect medium supplemented with 10% fetal bovine serum and antibiotics and were grown at 25°C without CO 2. Transfection of SL-2 cells was performed as previously described (13) . Specifically, 200 ng of rFcRn Ϫ157/ϩ135 /␤Gal were transfected with various amounts of Sp1 or Sp3 expression plasmids containing the Drosophila actin 5 promoter (pPacSp1 and pPacUSp3 were generously provided by Drs. R.
Tjian and G. Suske, respectively). ␤-Gal activity was expressed as relative light units per milligram of protein. The protein concentration was determined by bicinchoninic acid protein assay (Pierce).
DNase I Footprint Analysis
DNase I footprint analysis was performed to define the approximate region of protein-DNA interactions as previously described (20) . The rFcRn Ϫ216/ϩ135 /E-Luc vector was cut with HindIII, kinased with [␥-P 32 ]dATP (6,000 Ci/mol) and then cut with BglII. Samples were electrophoresed on a 5% polyacrylamide gel, purified, and diluted to 6,000 counts/min (cpm)/l. Footprints were performed with Caco-2 nuclear extracts that were dialyzed with 0.1 M KCl. Either nuclear extracts (6 g) or BSA was mixed with probe (6,000 cpm), and serial dilution of DNase I was added to the reaction buffer [in mM: 40 CaCl 2, 10 HEPES (pH 7.9), 0.1 EDTA, 0.05 KCl, 28 2-␤-mercaptoethanol, and 0.1 BSA, with 10% glycerol]. Samples were purified with phenol and chloroform, precipitated with ethanol, and run on a 6% polyacrylamide gel for 100 min at 50 W. The locations of the protein/DNA binding sites were determined by running a DNA ladder sequenced by the Maxam-Gilbert method.
EMSA and Preparation of Nuclear Extract
Nuclear extracts were obtained from both Caco-2 cells by standard methods as previously described, and recombinant Sp1 was also used for a limited number of studies (Promega) (21) . EMSA was performed using a series of double-stranded oligonucleotides, which were la- 
beled with Klenow fragments. The identities of each oligonucleotide used in this study are included in results. Approximately 2 ϫ 10 4 cpm of probe and 2.5-5 g nuclear extracts were used for each reaction. Standard competition studies were run using excess unlabeled oligonucleotide duplexes. Antisera against Sp1, Sp2, and Sp3 were purchased from Santa Cruz Biotechnology and were used to perform supershift studies.
RESULTS
Isolation and structure of the rat FcRn gene. Three overlapping bacteriophage plaques were confirmed by screening and ranged in size from 11 to 19 Kb. The clones were isolated and restriction mapped with various 5Ј, midregion, and 3Ј probes, and various regions (including 1.6-Kb SmaI, 6.8-, 3.3-, and 1.6-Kb EcoRI, and 8-Kb HindIII) were subcloned into pBluescript. The entire upstream region of the gene (2.6 Kb) along with each exon and intron-exon boundary was sequenced bidirectionally using standard dideoxy chain-termination reaction. The gene is composed of seven exons and is similar to other MHC class I genes with each domain encoded by a separate exon. In addition, the transmembrane and cytoplasmic domains are represented by two individual exons, and the exact intron-exon boundaries have been solved (data not shown). The transcriptional initiation site of the rat FcRn gene was determined by standard primer extension (data not shown) and RNase protection assays ( Fig. 2A) , and its location is depicted as a downward arrow in Fig. 1 .
Abundant Steady-State Levels of FcRn mRNA are Detectable in Caco-2, HT-29, IEC-6, and an Endothelial Cell Line
We performed Northern blot analysis for the FcRn mRNA transcript in several cell lines including Caco-2, HT-29, IEC-6, and a rodent endothelial (SVEC) cell line. As shown in Fig. 2B , the FcRn transcript was readily abundant in each of the cell lines tested, and these data were interpreted to suggest that these cells lines would be good candidates to perform functional analysis of the FcRn promoter.
DNase I Footprint Analysis of Core Promoter Identifies Several DNA-Protein Complexes
To determine the approximate location of the cis-elements that bind to nuclear extracts, Caco-2 extracts were used to perform DNase I footprint analysis of the core promoter region. These data demonstrate that as many as two distinct footprints (Ϫ26 to Ϫ61 and Ϫ90 to Ϫ121) and five hypersensitivity sites were identified within the gene's immediate promoter region in the presence of Caco-2 nuclear extracts (Fig. 2C) .
Transient Transfection of Clones Containing Various Lengths of the Upstream Region of the Rat FcRn Gene in Intestinal Cell Lines Identified the Core Promoter
To begin assessing the role of the various regions of the 5Ј-upstream portion of the FcRn gene, chimeric-luciferase reporter clones were transiently transfected into both Caco-2 and IEC-6 cells. Transfection of the full-length (rFcRn Ϫ2940/ϩ14 ) and sequentially shorter reporter constructs resulted in reporter activity in both cell lines that ranged from 100-to 40-fold higher than the empty pGL3-basic vector (data not shown). Comparable data were obtained with several clones that contain a shorter length of the 5Ј region of the FcRn promoter region subcloned upstream of the reporter vector pGL3-enhancer (Fig. 3A) . Reporter activity declined abruptly with clones shorter than FcRn
, suggesting that the core promoter region of the FcRn gene is located within nucleotides Ϫ157 and ϩ135.
Transient Transfection of the Clone Containing the Core Promoter Region of FcRn in Intestinal and Other Cell Lines Suggests that the Promoter Drives Primarily Intestinal-Specific Gene Expression
To assess the cell specificity of the core promoter region of the FcRn gene, we transiently transfected several intestinal (Caco-2, IEC-6, and m-IC cl2 ) and nonintestinal (3T3, CHO, and HeLa) cell lines. Maximum expression was obtained in the three intestinal cell lines, with the most abundant expression occurring in Caco-2 cells (Fig. 3B) . Whereas 3T3 cells supported the expression of the reporter, promoter activity in both CHO and HeLa cells was only marginal. These data suggest that the core promoter region (nt Ϫ157 and ϩ135) of the FcRn gene is sufficient to drive abundant expression in primarily cells of intestinal origin. Fig. 2 . A-C: identification of FcRn's transcriptional start site, mRNA abundance in several cell lines, and DNase I footprints. A: total RNA from the proximal intestine of a 15 day-old rat was hybridized with 32 P-labeled S2 and FcRn cRNA probes and precipitated without RNase digestion (lane 2). In contrast, lane 1 consists of the same RNA that was hybridized with the S2 cRNA probe and RNase digestion, whereas lane 4 was with an FcRn cRNA probe that was RNase digested. B: Northern blot analysis containing 2 independent samples of 20 g of RNA hybridized with either human (Caco-2, HT-29) or rat (IEC-6 and SVEC) cDNA probes. C: footprint analysis was performed with nuclear extracts isolated from Caco-2 cells (lanes 4 -6) or in the presence of BSA (lanes 1-3) . DNA was labeled in the sense orientation in the presence of increasing concentrations of DNase I. The filled rectangles on the right depict the location of the footprint, and * represents the location of the hypersensitivity sites.
Site-Directed Mutagenesis of the Core Promoter Revealed Two Critical Regions that Control Promoter Activity
To assess the critical regions within the core promoter (Ϫ157 to ϩ135) that are responsible for basal expression, a series of 20 clones was developed that contained 10 base pair mutations (Table 1 and Fig. 1 ). When these clones were transfected into either Caco-2 or IEC-6 cells, mutations in two specific regions were shown to dramatically influence promoter activity (Fig. 4) . In Caco-2 cells, promoter activity of the wild-type Ϫ157/ϩ135 clone was more than 120-fold greater than the empty pGL3-enhancer vector. Clones with mutations in the M8 -M11 regions had promoter activities that were ϳ25% of the wild-type rFcRn Ϫ157/ϩ135 clone. In contrast, promoter activities of the clones containing mutations in M15-M17 region were only 30% of the empty pGL3-enhancer vector. Similar albeit less dramatic results were obtained with IEC-6 cells.
These data were interpreted to suggest that the M8 -M11 and the M15-M17 regions interact with proteins that control basal expression of the FcRn promoter. The location of the DNAprotein footprints also corresponds to the approximate location of these two large transcriptional active sites (Fig. 2C) . Specifically, the footprint between Ϫ26 and Ϫ61 corresponds to the region mutated in the M8 -M11 clones, whereas the Ϫ90 and Ϫ121 complex overlaps the location of the M15-M17 mutations (Figs. 1, 2C , and 4). To assist in the identification of putative cis-acting elements in the core promoter region of the FcRn gene, we used the TRANSFAC database (8) . The analysis showed that the promoter was highly enriched with GC residues and identified as many as five potential Sp sites (Sp-A to Sp-E) within the immediate upstream region of the promoter and an additional Sp site (Sp-F) just upstream of the minimal promoter ( Figs. 1 and 5 ). Taken together, these data suggest the presence of at least two large distinct regions that are capable of binding to nuclear proteins and altering basal expression of the FcRn's core promoter region. Our subsequent analysis focused on exploring the potential role that the Sp family of proteins has in controlling basal expression of the rat FcRn minimal promoter.
EMSA's Identified Six Sp cis-Elements with Various Affinities to the Sp Family of Proteins
Sp-A, Sp-B, and Sp-C sites. To further evaluate the proteins responsible for controlling the basal promoter activity of the FcRn gene, we developed a series of double-stranded oligonucleotides to the M8 -M13 region of the promoter. EMSA performed with the Sp-A oligonucleotide that spans from Ϫ47 to Ϫ22 forms two specific complexes that supershift with antiserum to various members of the Sp family of transcriptional factors including Sp1, Sp2, and Sp3 (Fig. 6, lanes 1-9) . Specifically, the slower migrating complex is formed by binding of Sp1, Sp2, and other unidentified nuclear proteins, whereas the faster complex was entirely supershifted with an anti-Sp3 antibody. The Ϫ47/Ϫ22 probe was also capable of specifically binding recombinant Sp1 (Fig. 6, lanes 10 and 11) , and competition with a group of duplex oligonucleotides containing mutations in regions that span Ϫ47 to Ϫ22 confirmed that the complexes form by interacting with regions located between Ϫ28 to Ϫ39 (data not shown). This Sp1 site was named Sp-A, and it corresponds to a classic Sp1 consensus sequence (Figs. 5 and 6 ).
The gel shift assay performed with the Sp-B probe that spans nt Ϫ66 to Ϫ22 also forms two complexes with Caco-2 nuclear extracts (Fig. 7, lane 1) . Competition with 50-fold excess of a duplex wild-type oligonucleotide (Ϫ66 to Ϫ22) entirely competed for binding of the complexes (Fig. 7, lane 2) , whereas competition with oligonucleotides that contained mutations in the Sp-B site (⌬Ϫ61 to Ϫ47), failed to compete for any of the complexes (Fig. 7, lanes 4-6) . The identities of these complexes were confirmed using antiserum to Sp1, Sp2, and Sp3 (Fig. 7, lanes 8 -16) .
To identify the potential role of the more upstream Sp1 site, named Sp-C, we performed EMSA with a duplex oligonucleotide that spans Ϫ96 to Ϫ60 and contains only the Sp-C site. This Sp-C site forms two complexes that resemble the Sp family of proteins based on size as well as an intermediate smudge (Fig. 8, lanes 5 and 6) . These complexes are in contrast to the two predominant complexes seen when either the Sp-A or Sp-B probe was used alone (Fig. 8, lanes 1-4) . When a longer duplex oligonucleotide that spans Ϫ96 to Ϫ22 and contained the Sp-A, Sp-B, and Sp-C sites was labeled, three high-affinity complexes were detected (Fig. 8, lanes 11 and  12) . It should be noted that the slower migrating complex was faintly visible with labeled oligonucleotides that contained individual Sp-A and Sp-B sites (Fig. 8, lanes 1-4) , and we hypothesize that it may represent a multimerized form of the Sp family of proteins. Alternatively, the large complex (Fig. 8,  lane 11 ) may represent simultaneous binding of Sp proteins to adjacent cognate Sp elements. Interestingly, when a duplex oligonucleotide that spans Ϫ96 to Ϫ22 and contained a mutation in the Sp-C site (Sp-A-B-c; ⌬Ϫ78 to Ϫ69) was used as a probe, the two slower migrating complexes (1 and 2) were more abundant, suggesting that an intact Sp-C site impeded with the formation of 6 . The Sp-A element binds to members of the Sp family proteins. EMSA was performed using Caco-2 nuclear extracts and a labeled duplex oligonucleotide (Ϫ47/Ϫ22). Shown is a supershift analysis performed with different possible combinations of Sp1, Sp2, and Sp3 antiserum (lanes 1-9) . Recombinant Sp1 also bound and could be competed off with 100ϫ unlabeled Ϫ47/Ϫ22 oligonucleotide duplexes (lanes 10 and 11) . The element in this region is labeled as Sp-A and is shown as a rectangle in the top portion of the figure. The location of mutants M9 and M8 are also shown relative to Sp-A for comparison.
these complexes (Fig. 8, lanes 13 and 14) . Furthermore, the slower migrating complex failed to form when an oligonucleotide that spans Ϫ96 to Ϫ22 and contained a mutation in the Sp-A site (Sp-a-B-C; ⌬Ϫ41 to Ϫ22) was used (Fig. 8, lanes 15 and 16) , suggesting that the presence of both the Sp-A and Sp-B sites is required for the formation of the complex.
To investigate the relative affinity of the Sp-A, Sp-B, and Sp-C elements, EMSA was performed with 50-fold competition of unlabeled duplex oligonucleotides. The Sp-A element has the highest affinity site, because it competes with itself and the Sp-B site (Fig. 9, lanes 1-4 and 7-10) . In contrast, whereas the Sp-C site forms specific complexes, the site is only marginally capable of competing with Sp-A, while competing slightly better for the Sp-B site (Fig. 9, lanes 1-18) . Interestingly, neither the Sp-A nor Sp-B site was capable of competing for the intermediate smudge complex (Fig. 9, lanes 13-16) . Taken together, these data were interpreted to suggest the Sp-A and Sp-B sites bind to the Sp family of proteins (Sp1, Sp2, and Sp3) with high affinity, whereas the Sp-C site is a low-affinity Sp-element that is capable of interacting with a complex that is distinct from Sp at higher affinity. Moreover, the formation of the multimerized form of Sp requires the simultaneous presence of Sp-A and Sp-B, and that presence of Sp-C dampened the formation of this slow migrating complex.
Sp-D and Sp-E sites
To analyze the region of the promoter that was most adversely affected by the scanning mutagenesis of the promoter, duplex oligonucleotides (Ϫ125 to Ϫ87) were developed to the region spanning M15-M17, and it was named Sp-D-E (Figs. 1 and 4 ). EMSA performed with this probe formed two complexes that resemble the Sp family of proteins and a considerably fainter and slower migrating complex (Fig.  8, lanes 17-18) . The Sp family of proteins appeared to bind the Sp-E site, because a probe that contained exclusively the Sp-D site (with mutations in the Sp-E site; Sp-D-e) fails to form the Sp-proteins (Fig. 8, lanes 7-8 and 17-18) . In contrast, the slow migrating complex is specific for the Sp-D site, because the probe that contains Sp-E (with mutations in the Sp-D site; Sp-d-E) is incapable of forming this complex while retaining the ability to form complexes with Sp-proteins, albeit at lower affinity (Fig. 8, lanes 9 -10 and 17-18 ). These data demonstrate that the cognate Sp-E element appears to form an interaction with proteins that resemble Sp-proteins (based on size), whereas the Sp-D site interacts with a component of the nuclear extract that forms a large complex that appears to facilitate binding of Sp-proteins to the Sp-E element.
To further assess the characteristics of the Sp-D and Sp-E complexes, we performed EMSA-competition experiments with the unlabeled Sp-A, Sp-B, and Sp-C oligonucleotides. Competition of the Sp-D-E probe with either Sp-A or Sp-B entirely competed for binding of the Sp family of proteins while failing to compete for the slower migrating complex (Fig. 9, lanes 31-33) . Moreover, competition with the Sp-C and Sp-d-E oligonucleotides only partially competed for the Sp family of complexes, whereas the Sp-D-e oligonucleotides failed to compete entirely (Fig. 9, lanes 34 -36) . In contrast, Fig. 7 . The Sp-B element binds to members of the Sp family proteins. EMSA was performed with Caco-2 nuclear extracts, and a duplex oligonucleotide that spans Ϫ66 to Ϫ42 was labeled. Competition was performed with 100-fold excess of either wild-type or mutant unlabeled oligonucleotides (lanes 2-7) . The nucleotides mutated in each mutant oligonucleotide are indicated by ⌬, and their location is depicted below the nucleotide sequence. Supershift results using specific antiserum to Sp1, Sp2, and Sp3 are shown in various combinations (lanes 8 -15) . Nonreactive (NR) serum is used for comparison (lane 16). The location of the Sp-B element is displayed in the top region of the figure, and the location of the M10 and M11 mutations is shown for comparison. Fig. 8 . A size comparison of each of the complexes that interact with Sp-A to Sp-D. EMSA was performed with Caco-2 nuclear extracts and 9 duplex oligonucleotides that span from Sp-A to Sp-D, and their identities are discussed in the text. Competition was performed with 50-fold excess of the unlabeled wild-type oligonucleotide. Some oligonucleotides span several Sp sites, as indicated by the name of the probe. The uppercase letters that follow Sp is indicative of an intact element, whereas lowercase letters indicate that the probe contains a mutation within the particular Sp site.
removal of the Sp-D site (using probe Sp-d-E) interfered with the ability of even the high-affinity Sp-A site to compete for the Sp-complexes, although still retaining the ability to compete with the unlabeled Sp-d-E oligonucleotide (Fig. 9, lanes 25-30) . Moreover, the slower migrating complex was completed by excess of either the Sp-d-E or Sp-D-e oligonucleotides but not by Sp-A, Sp-B, or Sp-C (Fig. 9, lanes 19 -24) .
The identities of these complexes were assessed by supershift assay using antiserum specific for Sp1, Sp2, and Sp3. Labeling of the Sp-D-E oligonucleotides formed complexes that were supershifted with each of the three Sp antibodies confirming the identity of each complex (Fig. 10, lanes 1-9) . Similar results were obtained when the Sp-E element was assessed using the Sp-d-E oligonucleotide (Fig. 10, lanes  19 -27) . However, none of the antibodies was capable of interacting with the slower migrating protein that interacts with the Sp-D site as shown with the Sp-D-e oligonucleotides (Fig.  10, lanes 10 -18) . Overall, these data were interpreted to suggest that the Sp-D element binds an unidentified protein complex that is neither Sp1, Sp2, nor Sp3 and that this complex facilitates the binding of Sp-proteins to the Sp-E element.
Sp-F sites. An additional Sp site was identified with the use of duplex oligonucleotides that spans from nt Ϫ296 to Ϫ187 (Fig. 1) . The two complexes supershifted with antibodies that recognize the Sp family of proteins and resemble the pattern seen with the Sp-A site, and a mutation of the Sp-F site significantly reduced luciferase reporter activity (Fig. 1 , data not shown).
Drosophila SL2 Cells were Used to Confirm the Role of Sp1 and Sp3 in Driving Activity of FcRn's Minimal Promoter
To further assess the role of the Sp family of proteins in inducing FcRn's promoter activity, the rFcRn Ϫ157/ϩ135 /␤-Gal clone was cotransfected with various amounts of Sp1 (pPacSp1) and Sp3 (pPacUSp3) expression vectors in Spdeficient Drosophila SL2 cells. The data demonstrate that increasing concentrations of Sp1 augments FcRn promoter activity more than fourfold, whereas Sp3 increases activity ninefold (Fig. 11, A and B) .
DISCUSSION
In this study, we describe the initial characterization of the promoter region of the rat FcRn gene. Initial analysis of basal transcription using transfected reporter assays demonstrated that intestinal epithelial cells Caco-2 and IEC-6 support promoter activity of the 5Ј-upstream region of the FcRn gene, and deletion analysis revealed that the location of the gene's minimal promoter is approximately between nt Ϫ157 and ϩ135 relative to the start of transcription. Evidence of the formation of DNA-protein complexes was identified in the gene's minimal promoter by DNase footprint analysis, and site-directed mutagenesis confirmed that the complexes interact with specific cis-elements to control basal expression in intestinal cell lines.
A previous analysis of the human FcRn gene suggested the role of GC elements in the control of promoter activity; however, selective mutations that assessed the function of Fig. 9 . The relative ability of each Sp site to compete with one another. EMSA was performed with Caco-2 nuclear extracts and 6 duplex oligonucleotides that span from Sp-A to Sp-D. Competition was performed with 50-fold excess of the unlabeled oligonucleotides as specified. Fig. 10 . The Sp-D and Sp-E elements interact with specific complexes. EMSA was performed with Caco-2 nuclear extracts, and a duplex oligonucleotide that spans from Ϫ125 to Ϫ87 was labeled (Sp-D-E). Oligonucleotides that contained mutations in the Sp-E site (indicated Sp-D-e) or Sp-D site (indicated Sp-d-E) were also labeled. Supershift results using specific antiserum to Sp1, Sp2, and Sp3 are shown in various combinations. NR serum is used for comparison. The locations of the Sp-D and Sp-E elements are displayed in the top region of the figure, whereas the location of the M10 and M11 mutations is shown for comparison. these sites were not performed (22) . In the current study, we took an unbiased approach and assessed the entire minimal promoter region for potentially active cis-elements by performing scanning mutagenesis. The immediate upstream region of the rat promoter contains several GC elements that were mutated in the M8 -M11 clones, and transcriptional activities of these clones were significantly reduced in both Caco-2 and IEC-6 cells (Fig. 4) . These mutations disrupt binding of members of the Sp family of proteins to the Sp-A (Ϫ40/Ϫ29) and -B (Ϫ59/Ϫ50) sites and decrease activity to ϳ25% of the Ϫ157/ϩ135 wild-type clone (Fig. 4) . EMSA and supershift assays confirmed that both sites bind to members of the Sp family of proteins, including Sp1, Sp2, and Sp3 (Figs. 6 and 7) (24) . Specifically, the slower migrating complex was composed of Sp1, Sp2, and other unidentified complexes, whereas the faster migrating complex represents Sp3.
Although Sp1 is considered a ubiquitously expressed transcription factor, protein levels vary dramatically in different organs and cell lines (26) . Therefore, members of the Sp family of proteins play an important role in the regulation of many tissue and developmentally specific genes (21) . Moreover, the various members of the Sp-multigene family function as both transcriptional activators and repressors and may also interact directly with other transcriptional factors to control gene expression (6, 13, 26) . Phosphorylation of the DNA-binding domain of Sp1 and other zinc finger transcriptional factors has recently been shown to inactivate protein-DNA interactions and to inhibit transactivation (5) . Therefore, it is plausible that the multiple GC elements identified in the immediate promoter region of the FcRn gene may influence both the developmental and tissue expression of this gene.
Two additional Sp sites were also identified just downstream of Sp-A, which were labeled Sp-B (Ϫ59/Ϫ50) and Sp-C (Ϫ78/Ϫ69). In this region, the Sp-A element has the highest affinity to members of the Sp family of proteins, whereas the Sp-C site has lower affinity while also interacting with a yet unidentified complex. These findings are consistent with the transfection studies that showed disruption of the Sp-A site inhibited promoter activity to 25% of wild type, whereas mutation of the Sp-C site had luciferase levels that were 50% of wild type (Fig. 4) . The slowest migrating complex identified with the Sp-A-B-c probe in Fig. 8 most likely We also determined that the Sp-E site forms a complex with the Sp family of proteins, whereas the Sp-D element forms a complex with a slower migrating protein that appears to facilitate binding of Sp-proteins to the Sp-E element (Figs. 8 and 9 ). Interestingly, mutagenesis of these sites inhibited basal promoter activity more than 200-fold. Our interpretation of this data would be that disruption of either site (Sp-D and Sp-E) may either remove very potent positive transacting factors or, alternatively, could augment the binding of factors that suppress promoter activity. The current studies failed to decipher between these two possibilities. Whereas we confirmed that the Sp-D complex is neither Sp1, Sp2, nor Sp3, the data suggest that in its absence, the binding affinity of the Sp-E site for the Sp proteins declines considerably (Fig. 9) . Moreover, the Sp complexes that form with the Sp-d-E probe could not be competed with an excess of even the high-affinity Sp-A and Sp-B elements, suggesting that a protein other than Sp1, Sp2, and Sp3 could be binding to Sp-E in the absence of the Sp-D complex (Fig. 9) . The identity of the Sp-D complex remains unclear, and whether its removal augments the binding of other transcription factors to the Sp-E site has not been addressed in the current study.
Nevertheless, the transfection data do suggest that the absence of either the Sp-D or Sp-E sites does dramatically alter the activity of the core promoter region. Moreover, we hypothesize that the promoter activity of the FcRn gene may be controlled by either changes in the zinc concentrations, abundance of various Sp-proteins, or alteration of the phosphorylation state of zinc finger proteins (5) . Each of these manipulations will influence binding of these various Sp proteins to the gene's core promoter and alter activity. The physiological relevance of these sites in controlling the developmental repression expression of the FcRn gene in the intestine of weaned mice is currently under investigation.
Overall, this study represents the first detailed analysis of the elements that control the expression of the FcRn gene in any species. We have identified six specific elements located in the immediate upstream of the rat FcRn promoter that interact with members of the Sp family of proteins (Fig. 5) . The Sp proteins that interact with the Sp-A, -B, or -C sites moderately augment basal expression of the gene core promoter. In contrast, the complexes that form with the Sp-D and -E sites appear to dramatically repress basal expression of the gene. Nevertheless, the role that these elements have in controlling the expression of the FcRn gene in the developing animals has yet to be identified.
Whereas many genes that are expressed by small intestinal enterocytes are developmentally regulated at about the time of weaning, the FcRn and lactase-phlorizin hydrolase genes are the only well-characterized genes that decline in postweaned animals (9, 15) . Whereas lactase and FcRn expression are most abundant in the proximal intestine of suckling rodents, the FcRn transcript declines at weaning to undetectable levels throughout the intestine. In contrast, lactase expression in the proximal bowel of postweaned mice declines 50% compared with their preweaned littermates, whereas expression levels in the distal intestine decline to undetectable levels (10) . Therefore, FcRn appears to be rather unique among the various developmentally regulated genes of the small intestine, and further analysis of the mechanism that underlies its transcriptional control may lead to further insights into understanding the process of enterocyte development and differentiation.
